Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70) View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-04

AUTHORS

T. M. E. Davis, A. D. Wright, Z. M. Mehta, C. A. Cull, I. M. Stratton, G. F. Bottazzo, E. Bosi, I. R. Mackay, R. R. Holman

ABSTRACT

AIMS/HYPOTHESIS: We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset type 2 diabetes. METHODS: Patient clinical characteristics and autoantibody status were determined at entry to the UK Prospective Diabetes Study (UKPDS) before randomisation to different glucose control policies. Patients were followed for 10 years. RESULTS: Data available on 4,545 of the 5,102 UKPDS patients showed that 11.6% had antibodies to at least one of three antigens: islet cell cytoplasm, glutamic acid decarboxylase and islet autoantibody 2A (IA-2A). Autoantibody-positive patients were younger, more often Caucasian and leaner, with lower beta cell function and higher insulin sensitivity than autoantibody-negative patients. They also had higher HbA1c, and HDL-cholesterol levels, and lower blood pressure, total cholesterol and plasma triglyceride levels. Despite relative hyperglycaemia, autoantibody-positive patients were less likely to have the metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Program III), reflecting a more beneficial overall risk factor profile. Of 3,867 patients with post-dietary run-in fasting plasma glucose (FPG) values between 6.0 and 14.9 mmol/l and no hyperglycaemic symptoms, 9.4% were autoantibody-positive, compared with 25.1% of 678 patients with FPG values of 15.0 mmol/l or higher, or hyperglycaemic symptoms. In both groups, no differences were seen between those with and without autoantibodies in changes to HbA1c over time, but autoantibody-positive patients required insulin treatment earlier, irrespective of the allocated therapy (p<0.0001). CONCLUSIONS/INTERPRETATION: Autoantibody-positive patients can be treated initially with sulphonylurea, but are likely to require insulin earlier than autoantibody-negative patients. More... »

PAGES

695-702

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x

DOI

http://dx.doi.org/10.1007/s00125-005-1690-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050081029

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15729570


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diet Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutamate Decarboxylase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperglycemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fremantle Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415051.4", 
          "name": [
            "University of Western Australia, School of Medicine and Pharmacology, Fremantle Hospital, P.O. Box 480, 6959, Fremantle, Western Australia, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "T. M. E.", 
        "id": "sg:person.015216203142.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015216203142.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Queen's Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.415598.4", 
          "name": [
            "University Hospital, Birmingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wright", 
        "givenName": "A. D.", 
        "id": "sg:person.0612622266.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612622266.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oxford University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.410556.3", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehta", 
        "givenName": "Z. M.", 
        "id": "sg:person.01322014001.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322014001.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Churchill Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415719.f", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK", 
            "Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, OX3 7LJ, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cull", 
        "givenName": "C. A.", 
        "id": "sg:person.0637007241.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637007241.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oxford University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.410556.3", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stratton", 
        "givenName": "I. M.", 
        "id": "sg:person.01201354332.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201354332.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Bambino Ges\u00f9 Paediatric Hospital, Scientific Institute, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bottazzo", 
        "givenName": "G. F.", 
        "id": "sg:person.0723572726.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "San Raffaele Hospital", 
          "id": "https://www.grid.ac/institutes/grid.18887.3e", 
          "name": [
            "Diabetes and Endocrinology Unit, San Raffaele Vita-Salute University Hospital, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosi", 
        "givenName": "E.", 
        "id": "sg:person.01333476364.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333476364.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Monash University", 
          "id": "https://www.grid.ac/institutes/grid.1002.3", 
          "name": [
            "Department of Biochemistry and Molecular Biology, Monash University, 3800, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mackay", 
        "givenName": "I. R.", 
        "id": "sg:person.0601576533.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601576533.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oxford University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.410556.3", 
          "name": [
            "Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holman", 
        "givenName": "R. R.", 
        "id": "sg:person.01017043005.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017043005.08"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bmj.321.7258.405", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000154862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.1994.tb02032.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005779148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.1994.tb02032.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005779148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250100602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008359946", 
          "https://doi.org/10.1007/s001250100602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250100602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008359946", 
          "https://doi.org/10.1007/s001250100602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.42.2.359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011571363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.316.7134.823", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012312604"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)07019-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018881858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00400195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022043816", 
          "https://doi.org/10.1007/bf00400195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00400195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022043816", 
          "https://doi.org/10.1007/bf00400195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00400195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022043816", 
          "https://doi.org/10.1007/bf00400195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0168-8227(96)01281-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022887325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027902786", 
          "https://doi.org/10.1007/bf00280883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027902786", 
          "https://doi.org/10.1007/bf00280883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027902786", 
          "https://doi.org/10.1007/bf00280883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.2.452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028155316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1464-5491.2000.00359.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031079444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.19.2486", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033739611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(97)03062-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044239979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90013-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047651427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90013-u", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047651427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.52.5.1128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048102325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.10.2954", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051024719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.47.12.1857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070743744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diabetes.48.1.150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070743959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.18.12.1557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070746593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.19.1.60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070746872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.21.12.2191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070748075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-128-3-199802010-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073701989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082427369", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083312174", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-04", 
    "datePublishedReg": "2005-04-01", 
    "description": "AIMS/HYPOTHESIS: We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset type 2 diabetes.\nMETHODS: Patient clinical characteristics and autoantibody status were determined at entry to the UK Prospective Diabetes Study (UKPDS) before randomisation to different glucose control policies. Patients were followed for 10 years.\nRESULTS: Data available on 4,545 of the 5,102 UKPDS patients showed that 11.6% had antibodies to at least one of three antigens: islet cell cytoplasm, glutamic acid decarboxylase and islet autoantibody 2A (IA-2A). Autoantibody-positive patients were younger, more often Caucasian and leaner, with lower beta cell function and higher insulin sensitivity than autoantibody-negative patients. They also had higher HbA1c, and HDL-cholesterol levels, and lower blood pressure, total cholesterol and plasma triglyceride levels. Despite relative hyperglycaemia, autoantibody-positive patients were less likely to have the metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Program III), reflecting a more beneficial overall risk factor profile. Of 3,867 patients with post-dietary run-in fasting plasma glucose (FPG) values between 6.0 and 14.9 mmol/l and no hyperglycaemic symptoms, 9.4% were autoantibody-positive, compared with 25.1% of 678 patients with FPG values of 15.0 mmol/l or higher, or hyperglycaemic symptoms. In both groups, no differences were seen between those with and without autoantibodies in changes to HbA1c over time, but autoantibody-positive patients required insulin treatment earlier, irrespective of the allocated therapy (p<0.0001).\nCONCLUSIONS/INTERPRETATION: Autoantibody-positive patients can be treated initially with sulphonylurea, but are likely to require insulin earlier than autoantibody-negative patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-005-1690-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "48"
      }
    ], 
    "name": "Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)", 
    "pagination": "695-702", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ee9236ad488ceea47d774db1b91e6736c126d3260ac41d9339e03fddf8d63b7e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15729570"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-005-1690-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050081029"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-005-1690-x", 
      "https://app.dimensions.ai/details/publication/pub.1050081029"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13093_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-005-1690-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-005-1690-x'


 

This table displays all metadata directly associated to this object as RDF triples.

304 TRIPLES      21 PREDICATES      75 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-005-1690-x schema:about N08283d6366444ff2acdb25e3f88e8ee9
2 N0b786fd1b4bb476c978590e67155f3bf
3 N0c6277cbd9bf4f63988ee31012fb0397
4 N0e0b75f6354d43db89ea3b36c02c19c8
5 N170ec9a435d74058875ab935b26e4825
6 N1d86e7c86bfe4c10a0b97d8285843035
7 N213feac47c2749f2886f19231e989d79
8 N26a7be88bd534d3687e0a09bd1110696
9 N2eb545a5c7404c5bba630d6ec724f1df
10 N3140caf0c4d343ba9ee1e30a81389c82
11 N346f044e7f104603a03089d6b0ebc55b
12 N3f7e6a986b80447c9c667189fca35462
13 N56eee981777f44cd8add4ca6dbbe52e4
14 N5d679b01746e46029adbafa4ebe34c99
15 N6e5c81c7485548c3b05b2eaaea6cdb9f
16 N718340a00da74b9fa412c7ec1ff5389d
17 Nafd49b1371724695bb109c3e830922b2
18 Nb160a1b2b6a04a2b9b2835326d53a532
19 Nb587fc1856ce4ce48992157ba6223fcb
20 Nc5e839354ffb415db7437533708a42b4
21 Nce379ab85d6e48f3aba88300832f228e
22 Ndabc2f0c67554dc5a91c380301edb1c7
23 anzsrc-for:11
24 anzsrc-for:1103
25 schema:author Nc600324c43c6429da41dc8df7c86c7fb
26 schema:citation sg:pub.10.1007/bf00280883
27 sg:pub.10.1007/bf00400195
28 sg:pub.10.1007/s001250100602
29 https://app.dimensions.ai/details/publication/pub.1082427369
30 https://app.dimensions.ai/details/publication/pub.1083312174
31 https://doi.org/10.1001/jama.285.19.2486
32 https://doi.org/10.1016/0140-6736(90)90013-u
33 https://doi.org/10.1016/0168-8227(96)01281-8
34 https://doi.org/10.1016/s0140-6736(97)03062-6
35 https://doi.org/10.1016/s0140-6736(98)07019-6
36 https://doi.org/10.1046/j.1464-5491.2000.00359.x
37 https://doi.org/10.1111/j.1464-5491.1994.tb02032.x
38 https://doi.org/10.1136/bmj.316.7134.823
39 https://doi.org/10.1136/bmj.321.7258.405
40 https://doi.org/10.2337/diab.42.2.359
41 https://doi.org/10.2337/diabetes.47.12.1857
42 https://doi.org/10.2337/diabetes.48.1.150
43 https://doi.org/10.2337/diabetes.52.5.1128
44 https://doi.org/10.2337/diacare.18.12.1557
45 https://doi.org/10.2337/diacare.19.1.60
46 https://doi.org/10.2337/diacare.21.12.2191
47 https://doi.org/10.2337/diacare.26.10.2954
48 https://doi.org/10.2337/diacare.26.2.452
49 https://doi.org/10.7326/0003-4819-128-3-199802010-00001
50 schema:datePublished 2005-04
51 schema:datePublishedReg 2005-04-01
52 schema:description AIMS/HYPOTHESIS: We examined the prevalence of islet autoantibodies and their relationship to glycaemic control over 10 years in patients diagnosed clinically with new-onset type 2 diabetes. METHODS: Patient clinical characteristics and autoantibody status were determined at entry to the UK Prospective Diabetes Study (UKPDS) before randomisation to different glucose control policies. Patients were followed for 10 years. RESULTS: Data available on 4,545 of the 5,102 UKPDS patients showed that 11.6% had antibodies to at least one of three antigens: islet cell cytoplasm, glutamic acid decarboxylase and islet autoantibody 2A (IA-2A). Autoantibody-positive patients were younger, more often Caucasian and leaner, with lower beta cell function and higher insulin sensitivity than autoantibody-negative patients. They also had higher HbA1c, and HDL-cholesterol levels, and lower blood pressure, total cholesterol and plasma triglyceride levels. Despite relative hyperglycaemia, autoantibody-positive patients were less likely to have the metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Program III), reflecting a more beneficial overall risk factor profile. Of 3,867 patients with post-dietary run-in fasting plasma glucose (FPG) values between 6.0 and 14.9 mmol/l and no hyperglycaemic symptoms, 9.4% were autoantibody-positive, compared with 25.1% of 678 patients with FPG values of 15.0 mmol/l or higher, or hyperglycaemic symptoms. In both groups, no differences were seen between those with and without autoantibodies in changes to HbA1c over time, but autoantibody-positive patients required insulin treatment earlier, irrespective of the allocated therapy (p<0.0001). CONCLUSIONS/INTERPRETATION: Autoantibody-positive patients can be treated initially with sulphonylurea, but are likely to require insulin earlier than autoantibody-negative patients.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N08fa4ee758374a5188712ac362cc096b
57 Ned389105aca94efc9999eaa9b88bf2c9
58 sg:journal.1001482
59 schema:name Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)
60 schema:pagination 695-702
61 schema:productId N2f8e45451b8541ce83e055eb83f886e3
62 N4b3066bce02740d180a8044656697512
63 Ncd63cb0e54794ddda3bbaa4f8cd54b4a
64 Nd6afaa24c9f340d4b4ed432cd007631d
65 Ned20562fc5954df99abad2992ed91d52
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050081029
67 https://doi.org/10.1007/s00125-005-1690-x
68 schema:sdDatePublished 2019-04-11T14:31
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher Nec4a701382e64d128a7a0d620898f82a
71 schema:url https://link.springer.com/10.1007%2Fs00125-005-1690-x
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N08283d6366444ff2acdb25e3f88e8ee9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 N08fa4ee758374a5188712ac362cc096b schema:volumeNumber 48
79 rdf:type schema:PublicationVolume
80 N0b786fd1b4bb476c978590e67155f3bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Hyperglycemia
82 rdf:type schema:DefinedTerm
83 N0c6277cbd9bf4f63988ee31012fb0397 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Male
85 rdf:type schema:DefinedTerm
86 N0e0b75f6354d43db89ea3b36c02c19c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Prospective Studies
88 rdf:type schema:DefinedTerm
89 N170ec9a435d74058875ab935b26e4825 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Diabetes Mellitus, Type 2
91 rdf:type schema:DefinedTerm
92 N1d86e7c86bfe4c10a0b97d8285843035 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Blood Glucose
94 rdf:type schema:DefinedTerm
95 N213feac47c2749f2886f19231e989d79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Female
97 rdf:type schema:DefinedTerm
98 N222eb1fc373d40e0ad61e05ce9405ea8 rdf:first sg:person.01333476364.42
99 rdf:rest N58d36b7a435d4893a183c59199567da8
100 N2644f5e1284d49a39c7f16b9ecfaa330 rdf:first sg:person.01322014001.53
101 rdf:rest N507ab0aa043b4588b1123b6fbb7e6dc4
102 N26a7be88bd534d3687e0a09bd1110696 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Sulfonylurea Compounds
104 rdf:type schema:DefinedTerm
105 N2eb545a5c7404c5bba630d6ec724f1df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Aged
107 rdf:type schema:DefinedTerm
108 N2f8e45451b8541ce83e055eb83f886e3 schema:name pubmed_id
109 schema:value 15729570
110 rdf:type schema:PropertyValue
111 N3140caf0c4d343ba9ee1e30a81389c82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Autoantibodies
113 rdf:type schema:DefinedTerm
114 N346f044e7f104603a03089d6b0ebc55b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Adult
116 rdf:type schema:DefinedTerm
117 N3f7e6a986b80447c9c667189fca35462 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Insulin
119 rdf:type schema:DefinedTerm
120 N3f8ba2e0027744f0869de13f92d43589 schema:name Bambino Gesù Paediatric Hospital, Scientific Institute, Rome, Italy
121 rdf:type schema:Organization
122 N476d6de844ed483883274579c0d4cf69 rdf:first sg:person.01017043005.08
123 rdf:rest rdf:nil
124 N4b3066bce02740d180a8044656697512 schema:name nlm_unique_id
125 schema:value 0006777
126 rdf:type schema:PropertyValue
127 N507ab0aa043b4588b1123b6fbb7e6dc4 rdf:first sg:person.0637007241.52
128 rdf:rest N83c1ebe66b344b42a732a05424432b0b
129 N56eee981777f44cd8add4ca6dbbe52e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Body Weight
131 rdf:type schema:DefinedTerm
132 N58d36b7a435d4893a183c59199567da8 rdf:first sg:person.0601576533.64
133 rdf:rest N476d6de844ed483883274579c0d4cf69
134 N5d679b01746e46029adbafa4ebe34c99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Time Factors
136 rdf:type schema:DefinedTerm
137 N6151ee53515f428d90220e1a30b28871 rdf:first sg:person.0723572726.20
138 rdf:rest N222eb1fc373d40e0ad61e05ce9405ea8
139 N6e5c81c7485548c3b05b2eaaea6cdb9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Glycated Hemoglobin A
141 rdf:type schema:DefinedTerm
142 N718340a00da74b9fa412c7ec1ff5389d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Diet Therapy
144 rdf:type schema:DefinedTerm
145 N76862c80d48a4be48ad79f9746e8c5bb rdf:first sg:person.0612622266.32
146 rdf:rest N2644f5e1284d49a39c7f16b9ecfaa330
147 N83c1ebe66b344b42a732a05424432b0b rdf:first sg:person.01201354332.66
148 rdf:rest N6151ee53515f428d90220e1a30b28871
149 Nafd49b1371724695bb109c3e830922b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Lipoproteins
151 rdf:type schema:DefinedTerm
152 Nb160a1b2b6a04a2b9b2835326d53a532 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Cholesterol
154 rdf:type schema:DefinedTerm
155 Nb587fc1856ce4ce48992157ba6223fcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Middle Aged
157 rdf:type schema:DefinedTerm
158 Nc5e839354ffb415db7437533708a42b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Proportional Hazards Models
160 rdf:type schema:DefinedTerm
161 Nc600324c43c6429da41dc8df7c86c7fb rdf:first sg:person.015216203142.77
162 rdf:rest N76862c80d48a4be48ad79f9746e8c5bb
163 Ncd63cb0e54794ddda3bbaa4f8cd54b4a schema:name readcube_id
164 schema:value ee9236ad488ceea47d774db1b91e6736c126d3260ac41d9339e03fddf8d63b7e
165 rdf:type schema:PropertyValue
166 Nce379ab85d6e48f3aba88300832f228e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Treatment Outcome
168 rdf:type schema:DefinedTerm
169 Nd6afaa24c9f340d4b4ed432cd007631d schema:name doi
170 schema:value 10.1007/s00125-005-1690-x
171 rdf:type schema:PropertyValue
172 Ndabc2f0c67554dc5a91c380301edb1c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Glutamate Decarboxylase
174 rdf:type schema:DefinedTerm
175 Nec4a701382e64d128a7a0d620898f82a schema:name Springer Nature - SN SciGraph project
176 rdf:type schema:Organization
177 Ned20562fc5954df99abad2992ed91d52 schema:name dimensions_id
178 schema:value pub.1050081029
179 rdf:type schema:PropertyValue
180 Ned389105aca94efc9999eaa9b88bf2c9 schema:issueNumber 4
181 rdf:type schema:PublicationIssue
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:journal.1001482 schema:issn 0012-186X
189 1432-0428
190 schema:name Diabetologia
191 rdf:type schema:Periodical
192 sg:person.01017043005.08 schema:affiliation https://www.grid.ac/institutes/grid.410556.3
193 schema:familyName Holman
194 schema:givenName R. R.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017043005.08
196 rdf:type schema:Person
197 sg:person.01201354332.66 schema:affiliation https://www.grid.ac/institutes/grid.410556.3
198 schema:familyName Stratton
199 schema:givenName I. M.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201354332.66
201 rdf:type schema:Person
202 sg:person.01322014001.53 schema:affiliation https://www.grid.ac/institutes/grid.410556.3
203 schema:familyName Mehta
204 schema:givenName Z. M.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322014001.53
206 rdf:type schema:Person
207 sg:person.01333476364.42 schema:affiliation https://www.grid.ac/institutes/grid.18887.3e
208 schema:familyName Bosi
209 schema:givenName E.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333476364.42
211 rdf:type schema:Person
212 sg:person.015216203142.77 schema:affiliation https://www.grid.ac/institutes/grid.415051.4
213 schema:familyName Davis
214 schema:givenName T. M. E.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015216203142.77
216 rdf:type schema:Person
217 sg:person.0601576533.64 schema:affiliation https://www.grid.ac/institutes/grid.1002.3
218 schema:familyName Mackay
219 schema:givenName I. R.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601576533.64
221 rdf:type schema:Person
222 sg:person.0612622266.32 schema:affiliation https://www.grid.ac/institutes/grid.415598.4
223 schema:familyName Wright
224 schema:givenName A. D.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612622266.32
226 rdf:type schema:Person
227 sg:person.0637007241.52 schema:affiliation https://www.grid.ac/institutes/grid.415719.f
228 schema:familyName Cull
229 schema:givenName C. A.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637007241.52
231 rdf:type schema:Person
232 sg:person.0723572726.20 schema:affiliation N3f8ba2e0027744f0869de13f92d43589
233 schema:familyName Bottazzo
234 schema:givenName G. F.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20
236 rdf:type schema:Person
237 sg:pub.10.1007/bf00280883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027902786
238 https://doi.org/10.1007/bf00280883
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/bf00400195 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022043816
241 https://doi.org/10.1007/bf00400195
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s001250100602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008359946
244 https://doi.org/10.1007/s001250100602
245 rdf:type schema:CreativeWork
246 https://app.dimensions.ai/details/publication/pub.1082427369 schema:CreativeWork
247 https://app.dimensions.ai/details/publication/pub.1083312174 schema:CreativeWork
248 https://doi.org/10.1001/jama.285.19.2486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033739611
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/0140-6736(90)90013-u schema:sameAs https://app.dimensions.ai/details/publication/pub.1047651427
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/0168-8227(96)01281-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022887325
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/s0140-6736(97)03062-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044239979
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s0140-6736(98)07019-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018881858
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1046/j.1464-5491.2000.00359.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031079444
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/j.1464-5491.1994.tb02032.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005779148
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1136/bmj.316.7134.823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012312604
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1136/bmj.321.7258.405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000154862
265 rdf:type schema:CreativeWork
266 https://doi.org/10.2337/diab.42.2.359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011571363
267 rdf:type schema:CreativeWork
268 https://doi.org/10.2337/diabetes.47.12.1857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070743744
269 rdf:type schema:CreativeWork
270 https://doi.org/10.2337/diabetes.48.1.150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070743959
271 rdf:type schema:CreativeWork
272 https://doi.org/10.2337/diabetes.52.5.1128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048102325
273 rdf:type schema:CreativeWork
274 https://doi.org/10.2337/diacare.18.12.1557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746593
275 rdf:type schema:CreativeWork
276 https://doi.org/10.2337/diacare.19.1.60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746872
277 rdf:type schema:CreativeWork
278 https://doi.org/10.2337/diacare.21.12.2191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070748075
279 rdf:type schema:CreativeWork
280 https://doi.org/10.2337/diacare.26.10.2954 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051024719
281 rdf:type schema:CreativeWork
282 https://doi.org/10.2337/diacare.26.2.452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028155316
283 rdf:type schema:CreativeWork
284 https://doi.org/10.7326/0003-4819-128-3-199802010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073701989
285 rdf:type schema:CreativeWork
286 https://www.grid.ac/institutes/grid.1002.3 schema:alternateName Monash University
287 schema:name Department of Biochemistry and Molecular Biology, Monash University, 3800, Victoria, Australia
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.18887.3e schema:alternateName San Raffaele Hospital
290 schema:name Diabetes and Endocrinology Unit, San Raffaele Vita-Salute University Hospital, Milan, Italy
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.410556.3 schema:alternateName Oxford University Hospitals NHS Trust
293 schema:name Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.415051.4 schema:alternateName Fremantle Hospital
296 schema:name University of Western Australia, School of Medicine and Pharmacology, Fremantle Hospital, P.O. Box 480, 6959, Fremantle, Western Australia, Australia
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.415598.4 schema:alternateName Queen's Medical Centre
299 schema:name University Hospital, Birmingham, UK
300 rdf:type schema:Organization
301 https://www.grid.ac/institutes/grid.415719.f schema:alternateName Churchill Hospital
302 schema:name Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, OX3 7LJ, Oxford, UK
303 Diabetes Trials Unit, Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK
304 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...